Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Icu Medical (ICUI) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to 2.55%.

  • Icu Medical's EBITDA Margin rose 11600.0% to 2.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.23%, marking a year-over-year increase of 35200.0%. This contributed to the annual value of 1.8% for FY2024, which is 7900.0% up from last year.
  • Icu Medical's EBITDA Margin amounted to 2.55% in Q3 2025, which was up 11600.0% from 1.93% recorded in Q2 2025.
  • In the past 5 years, Icu Medical's EBITDA Margin ranged from a high of 11.42% in Q3 2021 and a low of 7.76% during Q1 2022
  • For the 5-year period, Icu Medical's EBITDA Margin averaged around 2.49%, with its median value being 1.65% (2023).
  • Per our database at Business Quant, Icu Medical's EBITDA Margin tumbled by -161200bps in 2022 and then surged by 94100bps in 2023.
  • Over the past 5 years, Icu Medical's EBITDA Margin (Quarter) stood at 7.0% in 2021, then crashed by -101bps to 0.04% in 2022, then crashed by -5296bps to 2.07% in 2023, then surged by 389bps to 5.98% in 2024, then crashed by -57bps to 2.55% in 2025.
  • Its EBITDA Margin stands at 2.55% for Q3 2025, versus 1.93% for Q2 2025 and 2.13% for Q1 2025.